Clinical Management of Diamond–Blackfan Anemia Syndromes and Other Inherited Ribosomal Disorders

Read full text Summarise with VIRAT
Authors: Thierry M Leblanc, Maurizio Miano
Cited by: 0
References: 37

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Diamond–Blackfan anemia syndrome (DBAS) and other inherited ribosomal disorders represent a unique subgroup of ribosomopathies with hematological manifestations, particularly erythroblastopenia and transfusion-dependent anemia. DBAS encompasses classic ribosomal protein gene mutations and a subset termed “DBA-other,” associated with mutations in genes such as GATA1 and TP53. Diagnosis hinges on genotype–phenotype correlation, with increasing detection in nonclassical presentations. Management includes corticosteroids, red blood cell (RBC) transfusions with iron chelation, and hematopoietic stem cell transplantation (HSCT) for steroid-refractory cases. DBAS carries a significant risk of clonal evolution and solid tumors, such as osteosarcoma and colorectal cancer, necessitating long-term surveillance. The chapter also addresses cartilage-hair hypoplasia (CHH), another ribosomopathy with overlapping anemia and immunodeficiency phenotypes, emphasizing supportive care and HSCT in severe cases. As treatment strategies evolve, including gene therapy and targeted agents, optimal management requires expert multidisciplinary care and adherence to updated international guidelines.

Fields of Study & Subjects

Blood disorders and treatments Immunodeficiency and Autoimmune Disorders Hematopoietic Stem Cell Transplantation

Publication details

Journal / source
Springer eBooks
Pages
309–325
Publication date
25 March 2026
Language
EN
Document type
Book chapter